We found that siRNA-mediated knockdown of BMI1 in Abrams cells and BMI1 inhibition by PTC-209 in all three canine OSA cell lines (Abrams, D17, Moresco) decreased cell proliferation in vitro based on colorimetric viability assays. The gene discussed is BMI1; the disease is obstructive sleep apnea syndrome.